The Wall Street Journal in a recent report citing unnamed individuals stated that the US Department of Justice was investigating UnitedHealth Group for potential Medicare fraud.

Stephen Hemsley hasn’t been CEO at UnitedHealth Group in nearly a decade yet he’s never really left. Hemsley, 72, has remained chairman and a major shareholder in the health care behemoth — and now is back in the CEO

It keeps getting worse for UnitedHealth Group Inc. investors, as a report of a criminal investigation into its Medicare practices sent the stock diving again in early Thursday trading.

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

Stephen Hemsley ran UnitedHealth Group for more than a decade. It's a different company after four years with Andrew Witty in charge.

Wall Street is wary of UnitedHealth Group's (UNH) near-term prospects after the company's sudden CEO shake-up and its pulling of 2025 financial guidance on Tuesday. Bank of America Securities, for one,

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs. Click to read why UNH is a Hold.